ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A parent or teacher rating scale for attention and focus shows significant attention difficulties, scoring at a certain level on a standardised checklist (confirm with trial site for exact score requirements)
- A clinical interview shows the child has 4 or more symptoms of inattention, as reported by a parent or assessed by a mental health professional
- The child is comfortable using a computer
- The child has a general intelligence score above 80, as measured by a standardised IQ test
Who may not be able to join:
- The child has psychosis (as reported by a parent), significant depression, autism (scoring 15 or higher on a specific social communication questionnaire), a psychotic disorder, vision or hearing problems, or any other condition that might affect their ability to complete the tasks involved in the trial
- The trial investigator does not believe it is in the child's best interest to continue participating
- The child does not follow the required training schedule during the trial
- Children who are already taking medication for ADHD at the time of joining will not be eligible for certain parts of the trial (specifically Aims 3 and 4)
- Children who begin behavioural or psychological treatment for ADHD during the training phase of the trial will not be eligible to continue
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julie Schweitzer, PhD, UC Davis MIND Institute
Phone: 916-703-0294
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Decrease in the amount of eye movements toward the distractors and/or shorter duration of fixation on distractors.; Decrease in the amount of head movements toward the distractors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.